Related Experiment Video
Updated: Oct 15, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway
J E Nör1, R S Mitra, M M Sutorik
1Department of Oral Medicine/Pathology/Oncology, University of Michigan School of Dentistry, Ann Arbor, MI, USA.
Abstract:
Thrombospondin-1 (TSP1) is a potent natural inhibitor of angiogenesis. Although TSP1 has been reported to induce endothelial cell apoptosis in vitro and to downregulate neovascularization in vivo, the molecular mechanisms that link these two processes have yet to be established. Here we report that TSP1 mediates endothelial cell apoptosis and inhibits angiogenesis in association with increased expression of Bax, decreased expression of Bcl-2, and processing of caspase-3 into smaller proapoptotic forms. The ability of TSP1 to induce both endothelial cell apoptosis in vitro and to suppress angiogenesis in vivo was blocked by the caspase-3 inhibitor z-DEVD-FMK. TSP1 also attenuated VEGF-mediated Bcl-2 expression in endothelial cells in vitro and angiogenesis in vivo. Furthermore, TSP1 induced endothelial cell apoptosis and inhibited neovascularization in sponge implants in SCID mice. We conclude that TSP1 induces endothelial cell apoptosis and inhibits neovascularization by altering the profile of survival gene expression and activating caspase-3.
Insights
Thrombospondin-1 (TSP1) inhibits new blood vessel formation by inducing endothelial cell apoptosis. This occurs via increased Bax, decreased Bcl-2, and caspase-3 activation, a process blocked by caspase-3 inhibitors.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Thrombospondin-1 (TSP1) is a known inhibitor of angiogenesis.
- The precise molecular mechanisms linking TSP1's induction of endothelial cell apoptosis and its anti-angiogenic effects remain unclear.
Purpose of the Study:
- To elucidate the molecular pathways through which TSP1 inhibits angiogenesis.
- To investigate the role of apoptosis-related proteins and caspases in TSP1-mediated anti-angiogenic effects.
Main Methods:
- Assessed changes in Bax and Bcl-2 expression in endothelial cells treated with TSP1.
- Investigated caspase-3 activation and processing in response to TSP1.
- Utilized caspase-3 inhibitor z-DEVD-FMK to block TSP1 effects in vitro and in vivo.
- Examined TSP1's impact on VEGF-mediated Bcl-2 expression.
- Evaluated TSP1's effect on neovascularization in SCID mouse sponge implants.
Main Results:
- TSP1 treatment increased Bax expression and decreased Bcl-2 expression in endothelial cells.
- TSP1 induced the processing of caspase-3 into proapoptotic forms.
- The caspase-3 inhibitor z-DEVD-FMK abrogated TSP1-induced endothelial cell apoptosis and angiogenesis inhibition.
- TSP1 attenuated VEGF-induced Bcl-2 expression and inhibited angiogenesis in vivo.
- TSP1 suppressed neovascularization in SCID mouse sponge implants.
Conclusions:
- TSP1 induces endothelial cell apoptosis and inhibits neovascularization by modulating the expression of survival genes (Bax, Bcl-2).
- Activation of caspase-3 is a critical mediator of TSP1's anti-angiogenic and pro-apoptotic functions.
- These findings clarify the molecular basis of TSP1's role in regulating blood vessel formation.
Related Concept Videos
Caspases
Regulation of Angiogenesis and Blood Supply
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
